Alzheimer's disease, oligomers, and inflammation

G Forloni, C Balducci - Journal of Alzheimer's Disease, 2018 - content.iospress.com
The production of soluble amyloid-β oligomers (AβOs) and the activation of inflammation are
two important early steps in the pathogenesis of Alzheimer's disease (AD). The central role …

Alzheimer's disease: How metal ions define β-amyloid function

KP Kepp - Coordination Chemistry Reviews, 2017 - Elsevier
Alzheimer's disease is increasingly recognized to be linked to the function and status of
metal ions, and recently, the amyloid hypothesis has been strongly intertwined with the …

FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice

Q Wang, J Yuan, Z Yu, LI Lin, Y Jiang, Z Cao… - Molecular …, 2018 - Springer
Accumulating studies suggest that overnutrition-associated obesity may lead to
development of type 2 diabetes mellitus and metabolic syndromes (MetS). MetS and its …

Dyslipidemia and the risk of Alzheimer's disease

C Reitz - Current atherosclerosis reports, 2013 - Springer
Whether cholesterol is implicated in the pathogenesis of Alzheimer's disease (AD) is still
controversial. Several studies that explored the association between lipids and/or lipid …

Depression and cognitive impairment—extrahepatic manifestations of NAFLD and NASH

M Colognesi, D Gabbia, S De Martin - Biomedicines, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and its complication non-alcoholic steatohepatitis
(NASH) are important causes of liver disease worldwide. Recently, a significant association …

Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort

M Ganguli, B Fu, BE Snitz, TF Hughes, CCH Chang - Neurology, 2013 - AAN Enterprises
Objective: We examined the incidence of mild cognitive impairment (MCI) and its potential
vascular risk factors in a prospective population-based study. Methods: An age-stratified …

Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management

RJ Ellis, MJ Marquine, M Kaul, JA Fields… - Nature Reviews …, 2023 - nature.com
People living with HIV are affected by the chronic consequences of neurocognitive
impairment (NCI) despite antiretroviral therapies that suppress viral replication, improve …

Alzheimer's disease due to loss of function: A new synthesis of the available data

KP Kepp - Progress in neurobiology, 2016 - Elsevier
Alzheimer's Disease (AD) is a highly complex disease involving a broad range of clinical,
cellular, and biochemical manifestations that are currently not understood in combination …

Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis

M Siervo, SL Harrison, C Jagger… - Journal of …, 2014 - journals.sagepub.com
Background: Metabolic syndrome (MetS) is associated with an increased risk of coronary
heart diseases and stroke. Results on the association of MetS with dementia and cognitive …

Copper imbalance in Alzheimer's disease: Convergence of the chemistry and the clinic

KP Kepp, R Squitti - Coordination Chemistry Reviews, 2019 - Elsevier
In this perspective we list the many clinical, histopathological, genetic and chemical
observations relating copper to Alzheimer's disease (AD). We summarize how the …